Active metronomic vinorelbine schedules decrease plasma interleukin-2 levels in mice with Lewis lung carcinoma
Author:
Affiliation:
1. Dipartimento di Medicina Clinica e Sperimentale, Università di Pisa, Pisa, Pisa, Italy
2. Dipartimento di Patologia Chirurgica, Medica, Molecolare e Dell'Area Critica, Università di Pisa
Funder
Pierre Fabre Pharma Srl
Publisher
Informa UK Limited
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology
Link
https://www.tandfonline.com/doi/pdf/10.1080/1120009X.2020.1819069
Reference23 articles.
1. Optimal biologic dose of metronomic chemotherapy regimens is associated with maximum antiangiogenic activity
2. Metronomic vinorelbine: Anti-angiogenic activity in vitro in normoxic and severe hypoxic conditions, and severe hypoxia-induced resistance to its anti-proliferative effect with reversal by Akt inhibition
3. Pharmacokinetics of metronomic chemotherapy: a neglected but crucial aspect
4. Does metronomic chemotherapy induce tumor angiogenic dormancy? A review of available preclinical and clinical data
5. Clinical, pharmacodynamic and pharmacokinetic results of a prospective phase II study on oral metronomic vinorelbine and dexamethasone in castration-resistant prostate cancer patients
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Induced Vascular Normalization—Can One Force Tumors to Surrender to a Better Microenvironment?;Pharmaceutics;2023-07-26
2. MOVIE: a phase I, open-label, multicenter study to evaluate the safety and tolerability of metronomic vinorelbine combined with durvalumab plus tremelimumab in patients with advanced solid tumors;ESMO Open;2022-12
3. Revisiting metronomic vinorelbine with mathematical modelling: a Phase I trial in lung cancer;Cancer Chemotherapy and Pharmacology;2022-07-22
4. Construction of a rabbit model with vinorelbine administration via peripherally inserted central catheter and dynamic monitoring of changes in phlebitis and thrombosis;Experimental and Therapeutic Medicine;2022-01-11
5. Metronomic chemotherapy regimens and targeted therapies in non-Hodgkin lymphoma: The best of two worlds;Cancer Letters;2022-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3